Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Law and Criminology (R0)

Elisabeth Anna Lümkea Andersen

Regulation of Biotechnological Risks in a Multi-Level System

An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA

&lt;p&gt;Introduction.- Scientific Background.- The European Court of Justice&amp;rsquo;s Decision on Genome Editing.- The Regulation of Genetically Modified Plants in the European Union.- The EU&amp;rsquo;s Obligations under WTO law and CETA.- EU Regulations on Genome Edited Plants under WTO Law and CETA.- The Future of Genome Edited Plants in the EU.- Concluding Remarks.- Summary of Results.&lt;/p&gt;

Eurasian Countries and Human Rights Protection: Perspectives and a Possible Mechanism for Cooperation.- Central Asia and International Law.- Study on Value and Implementation Mechanism of African Constitutions.- Concurrent Criminal Jurisdiction: A Challenge to the Concept of Traditional Jurisdictional RuleTransformation of International Economic Law: Contours and Ways of the New Regulation.- New Formats of BRICS Cooperation in Economics, Science and Technology (‘BRICS+’, ‘RRICS-Outreach’) in Light of Basic Principles of International Law Jus Cogens.- The Role of BRICS in the Formation of Regional Monetary Unions.- Use of SEZs for Development: National Policies of China and India and the Potential Legal Implications.- The Arbitrability of International Commercial Disputes Involving Economic Sanctions.

This book touches on a wide range of legal issues that the BRICS countries or the BRICS legal scholars particularly care about. Given the intensified geo-political competition, it is important for government officials and legal scholars around the word understand not only their own legal conceptions, but also those legal positions owned by the others, so as to construct an inclusive legal order that is acceptable to the largest majority of the global population. This book provides an insightful legal perspective of the BRICS countries and scholars, making up for the lack of English literature on the legal research of the BRICS.

The BRICS Legal Cooperation and Perspectives

This book suggests a new legal framework to improve coherence in the definition of human dignity in European biotech patent law, by way of a novel court structure. It will be of interest to researchers in the field of intellectual property law, patent law and human rights, as well as those working within biotechnology.

Human Dignity and Biotechnological Patent Law

Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application

This book examines the field of financial cooperation and regulation along the Belt and Road. By evaluating the relevant theories, investigating the different sectors and analysing the practices of the individual country case studies, the book presents a well-rounded portrait of the topic.&nbsp; &nbsp; &nbsp;The book draws from experiences of different jurisdictions and provides a thorough and comprehensive study of different sectors, such as banking, bond, transportation finance, professionals, and others. The&nbsp;chapter authors’ in-depth experience provides both an academic's and practitioner’s view into the variety of topics explored.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;This book is beneficial to undergraduate and postgraduate students, academics, financial professional, as well as law enforcement agencies and financial regulators who are interested in financial regulatory issues that have arisen as a result of China's Belt and Road Initiative.

This book examines the field of financial cooperation and regulation along the Belt and Road. By evaluating the relevant theories, investigating the different sectors and analysing the practices of the individual country case studies, the book presents a well-rounded portrait of the topic. &nbsp;&nbsp;&nbsp;&nbsp;The book draws from experiences of different jurisdictions and provides a thorough and comprehensive study of different sectors, such as banking, bond, transportation finance, professionals, and others. The&nbsp;chapter authors’ in-depth experience provides both an academic's and practitioner’s view into the variety of topics explored.&nbsp; &nbsp;&nbsp;This book is beneficial to undergraduate and postgraduate students, academics, financial professional, as well as law enforcement agencies and financial regulators who are interested in financial regulatory issues that have arisen as a result of China's Belt and Road Initiative.

Along the Belt and Road

Financial Cooperation and Regulation

Durch die Genomeditierung mit der Genschere CRISPR/Cas und den Einsatz künstlicher Intelligenz bei der Analyse genetischer Daten erleben wir eine neue Dimension der Gentechnik. Wir sind die Generation mit der Genschere. Die Ergebnisse reichen von blutdrucksenkenden Tomaten und Gentherapien gegen Krebs über die Schaffung bakterieller Chassis als molekulare Werkstätten bis hin zur Wiedergeburt des ausgestorbenen Schattenwolfs und der ersten (Er)Zeugung von Designer-Babys.

Wie weit dürfen wir gehen? Gehört unsere Zukunft der Genomarchitektur? Brauchen wir Gentechnik, um den Herausforderungen des Klimawandels zu begegnen? Rettet uns künstliche Intelligenz vor einer genetischen Datenflut – oder macht sie Gesundheit und Therapie zu einer unverständlichen Blackbox?
Neue genomische Techniken ermöglichen präzise Eingriffe in das Erbgut – ganz ohne erkennbare Spuren. Sie basieren auf unserem wachsenden Verständnis von Genen, deren Bausteinen, epigenetischen Faktoren und Funktionen. Besonders in der Pflanzenzüchtung finden sie zunehmend Anwendung.

Dieses Buch vermittelt anschaulich und verständlich die Entwicklung der modernen Gentechnologie. Es lädt dazu ein, ethische, gesellschaftliche und rechtliche Fragen zu diskutieren.

Neu in dieser Auflage: Das Kapitel Gene und Gesetze beleuchtet die rechtlichen Rahmenbedingungen der Gentechnik in Züchtung und Medizin. Das Thema künstliche Intelligenz wurde erweitert, andere Kapitel wurden aktualisiert.

Durch die Genomeditierung mit der Genschere CRISPR/Cas und den Einsatz künstlicher Intelligenz bei der Analyse genetischer Daten erleben wir eine neue Dimension der Gentechnik. Wir sind die Generation mit der Genschere. Die Ergebnisse reichen von blutdrucksenkenden Tomaten und Gentherapien gegen Krebs über die Schaffung bakterieller Chassis als molekulare Werkstätten bis hin zur Wiedergeburt des ausgestorbenen Schattenwolfs und der ersten (Er)Zeugung von Designer-Babys.
 Wie weit dürfen wir gehen? Gehört unsere Zukunft der Genomarchitektur? Brauchen wir Gentechnik, um den Herausforderungen des Klimawandels zu begegnen? Rettet uns künstliche Intelligenz vor einer genetischen Datenflut – oder macht sie Gesundheit und Therapie zu einer unverständlichen Blackbox?
 
 Neue genomische Techniken ermöglichen präzise Eingriffe in das Erbgut – ganz ohne erkennbare Spuren. Sie basieren auf unserem wachsenden Verständnis von Genen, deren Bausteinen, epigenetischen Faktoren und Funktionen. Besonders in der Pflanzenzüchtung finden sie zunehmend Anwendung.
 Dieses Buch vermittelt anschaulich und verständlich die Entwicklung der modernen Gentechnologie. Es lädt dazu ein, ethische, gesellschaftliche und rechtliche Fragen zu diskutieren.Neu in dieser Auflage
 : Das Kapitel Gene und Gesetze beleuchtet die rechtlichen Rahmenbedingungen der Gentechnik in Züchtung und Medizin. Das Thema künstliche Intelligenz wurde erweitert, andere Kapitel wurden aktualisiert.

Wie CRISPR und KI unser Leben verändern

Gentechnik im Wandel

This book provides a comprehensive and systematic analysis of the emerging fourth generation of Chinese investment treaties. It argues that these treaties are entering an exploratory phase, shaped by the concurrent evolution of both China’s foreign investment regulatory regime and the broader landscape of international investment law. The period has witnessed significant breakthroughs over the past five years, including the promulgation of China’s new Foreign Investment Law, the conclusion of the China-EU Comprehensive Agreement on Investment and the Regional Comprehensive Economic Partnership, and China’s active engagement in investment arbitration. Given China’s important role in the global investment regime, its fourth-generation investment treaties warrant particular attention. This book will be valuable not only for Chinese scholars and practitioners specializing in international investment treaties and arbitration, but also for their international counterparts seeking to understand China’s domestic investment reforms and their interactions with international investment treaties.

Progress, Prospects and Implications

The Emerging Fourth Generation of Chinese Investment Treaties

This book provides an in-depth understanding of how the highly strategic BRICS (Brazil, Russia, India, China, and South Africa) countries are planning and implementing their digital transformation processes. It focuses particularly on two essential, yet often neglected, aspects of digital transformation: the expansion of connectivity and the digitalization of public services. Throughout its chapters, this book maps the policies, regulations, governance mechanisms, and initiatives adopted by the BRICS to achieve the ambitious goal of becoming “smart” countries. In these nations, the functioning of the economy, society, and democratic governance is supported and enhanced by technology, leading to significant evolution.
Adopting a critical approach, this volume acknowledges that digital transformation processes are not exempt from criticism, despite offering unique opportunities for developing countries to become global leaders. In addition to mapping the digital transformation processes of the BRICS countries, this book provides valuable insights into their approaches, highlighting both limitations and notable success stories. These insights are beneficial for researchers, policymakers, and practitioners alike.
This volume is the result of an exceptional collaboration between CTS-FGV, the Center for Technology and Society at Fundação Getulio Vargas Law School, Rio de Janeiro, and UNU-EGOV, the United Nations University Operating Unit on Policy-Driven Electronic Governance.

How the BRICS Countries are Regulating their Digital Transformation

SmartBRICS

Roadmap to Successful Digital Health Ecosystems: A Global Perspective, Second Edition, explores the transformative integration of digital health technologies to enhance healthcare delivery and patient outcomes. This book provides a comprehensive overview of the evolving landscape of digital health, focusing on next-generation systems and the role of artificial intelligence in creating efficient healthcare ecosystems. The revised content covers topics such as regional implementation experiences, workforce management, and precision healthcare. New chapters highlight advancements in digital health technologies, case studies from Jamaica and Africa, and strategies for addressing fragmentation in healthcare systems. The book emphasizes ethical AI use and proactive, integrated healthcare approaches. For the academic audience, this revision serves as an essential resource, compiling cutting-edge research and practical applications that inform best practices in digital health. It equips researchers, educators, and practitioners with the knowledge needed to navigate the complexities of digital health ecosystems and drive innovation in their fields.

A Global Perspective

Roadmap to Successful Digital Health Ecosystems

Developments in Applied Microbiology and Biotechnology

Revolutionizing Microbial Technology: Unlocking the Potential of Artificial Intelligence explores the potential integration of artificial intelligence (AI) and machine learning in the fields of microbiology and biotechnology. The book delves into various applications of AI in microbiology across different sectors. This includes coverage of basic microbiology, identification and characterization of microbes, how AI can be implemented in microbiology laboratory practices, and how bioinformatics can help analyze microbial data and help understand complex biological systems. It discusses implementation of AI in healthcare for the diagnosis of microbial diseases and AI-driven microbial therapies and examines potential AI solutions for the acceleration, cost-effectiveness, and efficiency of the drug discovery and drug development process. Additional coverage includes the AI integration in the food and agricultural industries. Revolutionizing Microbial Technology provides a comprehensive understanding to researchers, academics, industry professionals and students of the potential of AI as an advance tool for microbial research and application.

Unlocking the Potential of Artificial Intelligence

Revolutionizing Microbial Technology

Modern China and International Economic Law

This book offers a structured exploration of China’s commercial arbitration system, beginning with its procedural foundations and jurisdictional framework, followed by an emphasis on due process, arbitrator skills, and the critical importance of upholding valid arbitration agreements. It delves into legal complexities surrounding the application of domestic law, international conventions like the CISG, and the integration of mediation in dispute resolution, while concluding with ethical standards for arbitrators to ensure fairness and credibility. Bridging procedural rigor, practical insights, and ethical imperatives, the work serves as a comprehensive guide for navigating China’s arbitration landscape, balancing academic analysis with actionable guidance for practitioners.

By A Chinese Practitioner

Commentaries on Commercial Arbitration in Modern China

LCF Studies in Commercial and Financial Law

Sustainability in Financial and Commercial Contracts

NEW YORK TIMES BESTSELLER • An explosive, deeply reported exposé of Johnson &amp; Johnson, one of America’s oldest and most trusted pharmaceutical companies—from an award-winning investigative journalist “A damning portrait.”—Associated Press “A page-turning drama that raises life-or-death questions about the world’s largest healthcare conglomerate.”—Jonathan Eig, Pulitzer Prize–winning author of King: A Life FINALIST FOR THE NATIONAL BOOK CRITICS CIRCLE AWARD AND THE LOS ANGELES TIMES BOOK PRIZE • A CHICAGO PUBLIC LIBRARY AND NEW YORK PUBLIC LIBRARY BEST BOOK OF THE YEAR One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson &amp; Johnson. Her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry—for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light-years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson’s Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.

NEW YORK TIMES BESTSELLER • An explosive, deeply reported exposé of Johnson &amp; Johnson, one of America’s oldest and most trusted pharmaceutical companies—from an award-winning investigative journalist “A damning portrait.”—Associated Press “A page-turning drama that raises life-or-death questions about the world’s largest healthcare conglomerate.”—Jonathan Eig, Pulitzer Prize–winning author of King: A Life FINALIST FOR THE NATIONAL BOOK CRITICS CIRCLE AWARD • A CHICAGO PUBLIC LIBRARY AND NEW YORK PUBLIC LIBRARY BEST BOOK OF THE YEAR One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson &amp; Johnson. Her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry—for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light-years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson’s Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.

The Dark Secrets of Johnson & Johnson

No More Tears

Agentic Systems for Smarter Medicine

Self-Learning AI in Healthcare

Regulation of Biotechnological Risks in a Multi-Level System

Weitere Titel zum Thema